In this episode of Science Natters, we learn about a recent study authored by Professor Lali Medina-Kauwe from Cedars-Sinai Medical Center in the US.

In this study, Professor Medina-Kauwe and her team show that a new bioengineered protein that they have created, called HPK, is able to cross the blood-brain barrier and deliver targeted cancer drugs directly to brain tumours. This new therapeutic method could revolutionise the treatment of aggressive cancers and improve outcomes for patients with brain tumours.

Read the paper - doi: 10.1038/s41565-025-01867-7

Download the transcript and discover more episodes at sciencenatters.com